content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY>
  
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">UNITED STATES</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM 8-K</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pursuant to Section 13 or 15 (d) of the</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Securities Exchange Act of 1934</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  July 3, 2013</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">GLOBAL BIOTECH CORP..</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Delaware</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of incorporation)</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 65%">
  <TR STYLE="vertical-align: top; text-align: left">
      <TD STYLE="width: 49%; text-align: center; vertical-align: bottom">(Commission file no.)</TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="width: 49%; text-align: center; vertical-align: bottom">(IRS Employer Identification No.)</TD></TR>
  <TR STYLE="vertical-align: top; text-align: left">
      <TD STYLE="text-align: center; vertical-align: bottom">000-33271</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center; vertical-align: bottom">98-022951</TD></TR>
  </TABLE>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">2711, CENTREVILLE ROAD, BUREAU 400</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">WILMINGTON, DELAWARE 19808</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 12pt Courier New, Courier, Monospace; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">Company's telephone number,
  including area code:</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">302-288-0658</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><B>Item 5.02 Appointment of Directors or Certain
  Officers</B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Effective July 3, 2013, Leonard Stella was appointed the Chief Executive
  Officer and a Director of the Company. Mr.Stella&#8217;s appointment was confirmed at a meeting of the Board of Directors of the
  Company held on the same day. Mr. Stella aged 52, will serve as the CEO of the company until further notice.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 12pt Courier New, Courier, Monospace; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr. Stella
  has a Bachelor of Arts from McGill University, and received his Graduate Diploma in Administration from Concordia University in
  1986. In 1987 Mr. Stella founded and operated a residential and commercial property developer, Dominion City Developments. In 1991,
  he founded Trans-Immobilia, a residential property company.In 1997 he became the principal founding partner and Chief Executive
  Officer of Millenia Hope Inc, which he ran until 2010. In 2010 he became involved with Global as its head of development</FONT>
  <FONT STYLE="font-family: Times New Roman, Times, Serif">and strategic planning, given his expertise in M &amp; A and keen eye
  in identifying scientific technologies. In July 2013 its CEO and a Director.</FONT></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Effective July 3, 2013, Yehuda Kops was appointed the Chief Financial
  Officer and a Director of the Company. Mr.Kops&#8217; appointment was confirmed at a meeting of the Board of Directors of the Company
  held on the same day. Mr. Kops aged 59, will serve as the CFO of the company until further notice.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bachelor of Commerce (distinction) - McGill
  University (1974), Diploma in Management McGill (1976). In 1976 he received his Chartered Accountancy degree from the Order of
  Chartered Accountants of Canada. From 1978 until 1999, Mr. Kops practiced in public accounting, running his own firm specializing
  in accounting and finance, for small and medium sized enterprises. In 1999 he joined Millenia as their chief internal accountant
  and became Chief Operating Officer, until 2010. In 2010 he became the comptroller and main financial resource of Global Biotech.
  In July 2013 he became its CFO and a Director</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Global is in the process of forming an advisory
  Board to recommend and advise in both the technical and fiscal aspects of its business undertakings. Nominations to this new Board
  will be forthcoming shortly</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of February 28, 2013 Global Biotech Corp.&#8217;s
  Head office remains in Wilmington, Delaware. As of that date it had no Canadian office.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">Signatures</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">Pursuant to the requirements of the Securities
  Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">Date: August 23, 2013</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">Global Biotech Corp.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><U>By: /s/ Louis Greco</U></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">Louis Greco, President</P>
  
  
  <!-- Field: Page; Sequence: 2; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "gbiq8k082313.htm", "secsgml_size_bytes": 10260}]
metadata_filer: {"company-data": {"conformed-name": "Global Biotech Corp.", "cik": "0001126162", "assigned-sic": "7389", "irs-number": "980229951", "fiscal-year-end": "0228"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-33271", "film-number": "131056793"}, "business-address": {"street1": "2550 BATES RD.", "street2": "SUITE 212", "city": "MONTREAL", "state": "A8", "zip": "H3S 1A7", "phone": "302 288 0658"}, "mail-address": {"street1": "2711 CENTERVILLE", "street2": "SUITE 400", "city": "WILMINGTON", "state": "DE", "zip": "19808"}, "former-company": {"former-conformed-name": "SWORD COMP SOFT CORP", "date-changed": "20001011"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15 (d) of the
  Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  July 3, 2013
  GLOBAL BIOTECH CORP..
  (Exact name of registrant as specified in its
  charter)
  Delaware
  (State or other jurisdiction of incorporation)
  (Commission file no.)
  (IRS Employer Identification No.)
  000-33271
  98-022951
  2711, CENTREVILLE ROAD, BUREAU 400
  WILMINGTON, DELAWARE 19808
  Company's telephone number,
  including area code:
  302-288-0658
  Item 5.02 Appointment of Directors or Certain
  Officers
  Effective July 3, 2013, Leonard Stella was appointed the Chief Executive
  Officer and a Director of the Company. Mr.Stella's appointment was confirmed at a meeting of the Board of Directors of the
  Company held on the same day. Mr. Stella aged 52, will serve as the CEO of the company until further notice.
  Mr. Stella
  has a Bachelor of Arts from McGill University, and received his Graduate Diploma in Administration from Concordia University in
  1986. In 1987 Mr. Stella founded and operated a residential and commercial property developer, Dominion City Developments. In 1991,
  he founded Trans-Immobilia, a residential property company.In 1997 he became the principal founding partner and Chief Executive
  Officer of Millenia Hope Inc, which he ran until 2010. In 2010 he became involved with Global as its head of development
  and strategic planning, given his expertise in M & A and keen eye
  in identifying scientific technologies. In July 2013 its CEO and a Director.
  Effective July 3, 2013, Yehuda Kops was appointed the Chief Financial
  Officer and a Director of the Company. Mr.Kops' appointment was confirmed at a meeting of the Board of Directors of the Company
  held on the same day. Mr. Kops aged 59, will serve as the CFO of the company until further notice.
  Bachelor of Commerce (distinction) - McGill
  University (1974), Diploma in Management McGill (1976). In 1976 he received his Chartered Accountancy degree from the Order of
  Chartered Accountants of Canada. From 1978 until 1999, Mr. Kops practiced in public accounting, running his own firm specializing
  in accounting and finance, for small and medium sized enterprises. In 1999 he joined Millenia as their chief internal accountant
  and became Chief Operating Officer, until 2010. In 2010 he became the comptroller and main financial resource of Global Biotech.
  In July 2013 he became its CFO and a Director
  Global is in the process of forming an advisory
  Board to recommend and advise in both the technical and fiscal aspects of its business undertakings. Nominations to this new Board
  will be forthcoming shortly
  As of February 28, 2013 Global Biotech Corp.'s
  Head office remains in Wilmington, Delaware. As of that date it had no Canadian office.
  Signatures
  Pursuant to the requirements of the Securities
  Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Date: August 23, 2013
  Global Biotech Corp.
  By: /s/ Louis Greco
  Louis Greco, President